AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.110
-0.030 (-2.63%)
At close: Jan 2, 2026, 4:00 PM EST
1.110
0.00 (0.00%)
After-hours: Jan 2, 2026, 4:04 PM EST
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $30.42 million as of January 2, 2026. Its market cap has decreased by -28.81% in one year.
Market Cap
30.42M
Enterprise Value
-32.33M
1-Year Change
-28.81%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $30.42M, a decrease of -89.18%. That is a compound annual growth rate of -44.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |